Exova Group PLC Exova appoints Paul Barry as MD for Europe
04 Novembre 2015 - 11:30AM
RNS Non-Regulatory
TIDMEXO
Exova Group PLC
04 November 2015
4 November 2015
Exova appoints Paul Barry as managing director Europe
Global testing group Exova has appointed Paul Barry as managing
director for Europe and a member of its Group Executive
Committee.
Paul joins Exova following six years with Bureau Veritas, where
he most recently held the position of chief executive officer,
North West Europe. Originally joining the company as CEO, United
Kingdom and Ireland in 2009, Paul was latterly responsible for
revenues of over EUR200 million and 1,500 employees across eight
countries.
With over 25 years' experience in commercial and operational
management across a number of business sectors, he has held senior
roles with companies including British Gas, Transco, National Grid
and Germanischer Lloyd, and was managing director of Advantica's
Middle East business.
At Exova, Paul will be responsible for 64 facilities in 12
countries and will lead a team of over 1,700 testing and
calibration experts supporting customers in sectors including
aerospace, industrials, energy and health sciences.
Ian El-Mokadem, chief executive officer of Exova, said: "Paul
brings excellent credentials in leading and growing major
businesses. Well versed in a variety of relevant industries, such
as energy, utilities and infrastructure, and with a solid track
record working with pan-European teams, Paul is highly driven and
committed to strengthening and growing our European business."
Paul will report directly to Ian El-Mokadem.
ENDS
All media enquiries, please contact:
Devan LaBrash
Pagoda Porter Novelli
T: +44 131 556 0770
E: devan.labrash@pagodapr.com
Stuart Neill, Group Communications Manager, Exova
Tel. +44 131 335 4371 / +44 7799 365 043
E: stuart.neill@exova.com
Ian Middleton or Sophie Moate
Powerscourt
T: +44 (0)20 7250 1446
E: exova@powerscourt-group.com
Exova
Exova is one of the world's leading laboratory-based testing
groups, trusted by organisations to test and advise on the safety,
quality and performance of their products and operations.
Headquartered in Edinburgh, UK, Exova operates 143 laboratories and
offices in 32 countries and employs around 4,500 people throughout
Europe, the Americas, the Middle East and Asia/Asia Pacific.
Exova's capabilities help to extend asset life, bring
predictability to applications, and shorten the time to market for
customers' products, processes and materials. With over 90 years'
experience, Exova specialises in testing across a number of key
sectors from health sciences to aerospace, transportation, oil and
gas, fire and construction.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRADMMGMLDKGKZG
(END) Dow Jones Newswires
November 04, 2015 05:30 ET (10:30 GMT)
Grafico Azioni Exova (LSE:EXO)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Exova (LSE:EXO)
Storico
Da Set 2023 a Set 2024